| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $0.3701 ▼ -0.71% | Yesterday | $0.3738 ▲ +0.30% | Tomorrow's GT Biopharma Inc. Common Stock (GTBP) setup is anchored to $0.3727 and targets $0.3701 (-0.71%). The near-term read is downside; watch $0.3839 / $0.3615 because daily realized volatility is about 3.65%. |
Tomorrow's GT Biopharma Inc. Common Stock (GTBP) setup is anchored to $0.3727 and targets $0.3701 (-0.71%). The near-term read is downside; watch $0.3839 / $0.3615 because daily realized volatility is about 3.65%. | ||||
| Week | $0.3645 ▼ -2.20% | Last Week | $0.3761 ▲ +0.92% | The 7-day GT Biopharma Inc. Common Stock model moves from $0.3761 to $0.3645 (-2.20%). It gives downside momentum context for this stock, so breaks around $0.3839 / $0.3615 matter more than a single tick. |
The 7-day GT Biopharma Inc. Common Stock model moves from $0.3761 to $0.3645 (-2.20%). It gives downside momentum context for this stock, so breaks around $0.3839 / $0.3615 matter more than a single tick. | ||||
| Month | $0.3552 ▼ -4.69% | Last Month | $0.3800 ▲ +1.97% | The 1-month GT Biopharma Inc. Common Stock target is $0.3552 (-4.69%), compared with the live reference near $0.3727. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month GT Biopharma Inc. Common Stock target is $0.3552 (-4.69%), compared with the live reference near $0.3727. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $0.3414 ▼ -8.41% | Last Year | $0.3859 ▲ +3.53% | The 1-year GT Biopharma Inc. Common Stock scenario points to $0.3414 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year GT Biopharma Inc. Common Stock scenario points to $0.3414 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $0.3088 ▼ -17.14% | 5 Years Ago | $0.3995 ▲ +7.20% | The 5-year GT Biopharma Inc. Common Stock view is $0.3088 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year GT Biopharma Inc. Common Stock view is $0.3088 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $0.3727 | Mid |
| Daily Change | +0.38% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 58% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $0.3727 | Daily Change | +0.38% |
| Market Cap | $11.76M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.